Companies included in IBBQ
This is IBBQ's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–100 of 267.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| Invesco Private Prime Fund | Invesco Private Prime Fund | 10,825,716.741 | NS | 14.292793% |
| GILD | Gilead Sciences, Inc. | 48,865 | NS | 9.609457% |
| VRTX | Vertex Pharmaceuticals Inc. | 14,178 | NS | 9.300006% |
| AMGN | Amgen Inc. | 17,796 | NS | 9.119974% |
| REGN | Regeneron Pharmaceuticals, Inc. | 5,839 | NS | 6.025906% |
| Invesco Private Government Fund | Invesco Private Government Fund | 4,201,476.69 | NS | 5.547054% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 7,470 | NS | 3.283378% |
| INSM | Insmed Inc. | 12,065 | NS | 2.378673% |
| BIIB | Biogen Inc. | 8,295 | NS | 2.100732% |
| ARGX | argenx SE | 1,648 | NS | 1.668659% |
| UTHR | United Therapeutics Corp. | 2,437 | NS | 1.621289% |
| MRNA | Moderna, Inc. | 22,109 | NS | 1.563692% |
| ILMN | Illumina, Inc. | 8,646 | NS | 1.53486% |
| ROIV | Roivant Sciences Ltd. | 39,369 | NS | 1.504227% |
| INCY | Incyte Corp. | 11,115 | NS | 1.486109% |
| RPRX | Royalty Pharma PLC | 24,171 | NS | 1.474657% |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | 10,938 | NS | 1.473275% |
| VTRS | Viatris Inc. | 65,178 | NS | 1.284758% |
| ASND | Ascendis Pharma A/S | 3,474 | NS | 1.07097% |
| NBIX | Neurocrine Biosciences, Inc. | 5,641 | NS | 0.984946% |
| IONS | Ionis Pharmaceuticals, Inc. | 9,163 | NS | 0.981718% |
| Sanofi | Sanofi | 14,988 | NS | 0.962889% |
| BBIO | BridgeBio Pharma, Inc. | 10,918 | NS | 0.958285% |
| MEDP | Medpace Holdings, Inc. | 1,593 | NS | 0.950132% |
| SMMT | Summit Therapeutics Inc. | 42,174 | NS | 0.923744% |
| GH | Guardant Health, Inc. | 7,319 | NS | 0.907356% |
| BMRN | BioMarin Pharmaceutical Inc. | 10,885 | NS | 0.887126% |
| EXEL | Exelixis, Inc. | 15,175 | NS | 0.882742% |
| JAZZ | Jazz Pharmaceuticals PLC | 3,442 | NS | 0.863516% |
| BNTX | BioNTech SE | 5,726 | NS | 0.83332% |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | 1,784 | NS | 0.746622% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,287 | NS | 0.734045% |
| IBRX | ImmunityBio, Inc. | 55,881 | NS | 0.721545% |
| TEM | Tempus AI, Inc. | 9,809 | NS | 0.689612% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 7,676 | NS | 0.6412% |
| PRAX | Praxis Precision Medicines, Inc. | 1,420 | NS | 0.63133% |
| AXSM | Axsome Therapeutics, Inc. | 2,849 | NS | 0.616461% |
| HALO | Halozyme Therapeutics, Inc. | 6,671 | NS | 0.612384% |
| PCVX | Vaxcyte, Inc. | 7,425 | NS | 0.605234% |
| KRYS | Krystal Biotech, Inc. | 1,646 | NS | 0.599008% |
| CYTK | Cytokinetics, Inc. | 6,884 | NS | 0.565498% |
| Nuvalent, Inc. | Nuvalent, Inc. | 4,101 | NS | 0.551998% |
| Abivax S.A. | Abivax S.A. | 3,337 | NS | 0.534325% |
| Arcellx, Inc. | Arcellx, Inc. | 3,276 | NS | 0.492162% |
| KYMR | Kymera Therapeutics, Inc. | 4,067 | NS | 0.490505% |
| RYTM | Rhythm Pharmaceuticals, Inc. | 3,774 | NS | 0.462043% |
| COGT | Cogent Biosciences, Inc. | 8,738 | NS | 0.448191% |
| PTGX | Protagonist Therapeutics, Inc. | 3,560 | NS | 0.432789% |
| CRSP | CRISPR Therapeutics AG | 5,417 | NS | 0.430113% |
| CAI | Caris Life Sciences, Inc. | 15,855 | NS | 0.421586% |
| PTCT | PTC Therapeutics, Inc. | 4,553 | NS | 0.409901% |
| ALKS | Alkermes PLC | 9,274 | NS | 0.368548% |
| IMVT | Immunovant, Inc. | 9,812 | NS | 0.359226% |
| CGON | CG Oncology, Inc. | 4,605 | NS | 0.357493% |
| MIRM | Mirum Pharmaceuticals, Inc. | 2,923 | NS | 0.356159% |
| SRRK | Scholar Rock Holding Corp. | 5,710 | NS | 0.333738% |
| Amicus Therapeutics, Inc. | Amicus Therapeutics, Inc. | 17,240 | NS | 0.32708% |
| AMRX | Amneal Pharmaceuticals, Inc. | 17,835 | NS | 0.325183% |
| GPCR | Structure Therapeutics Inc. | 3,736 | NS | 0.310649% |
| ACAD | Acadia Pharmaceuticals Inc. | 9,567 | NS | 0.310216% |
| INDV | Indivior Pharmaceuticals, Inc. | 6,991 | NS | 0.302004% |
| NewAmsterdam Pharma Co. N.V. | NewAmsterdam Pharma Co. N.V. | 6,442 | NS | 0.301592% |
| CRNX | Crinetics Pharmaceuticals, Inc. | 5,407 | NS | 0.293399% |
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | 1,101 | NS | 0.288265% |
| ERAS | Erasca, Inc. | 15,831 | NS | 0.285509% |
| APGE | Apogee Therapeutics, Inc. | 3,075 | NS | 0.284187% |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | 5,023 | NS | 0.279326% |
| ADMA | ADMA Biologics, Inc. | 13,305 | NS | 0.273504% |
| XENE | Xenon Pharmaceuticals Inc. | 4,390 | NS | 0.250559% |
| SYRE | Spyre Therapeutics, Inc. | 4,352 | NS | 0.247126% |
| ARQT | Arcutis Biotherapeutics, Inc. | 6,836 | NS | 0.243413% |
| EWTX | Edgewise Therapeutics, Inc. | 5,934 | NS | 0.23848% |
| TARS | Tarsus Pharmaceuticals, Inc. | 2,367 | NS | 0.236005% |
| SUPN | Supernus Pharmaceuticals, Inc. | 3,195 | NS | 0.230864% |
| DNLI | Denali Therapeutics Inc. | 8,178 | NS | 0.228683% |
| VCYT | Veracyte, Inc. | 4,424 | NS | 0.213716% |
| BEAM | Beam Therapeutics Inc. | 5,686 | NS | 0.21365% |
| ALMS | Alumis Inc. | 5,443 | NS | 0.213358% |
| TWST | Twist Bioscience Corp. | 3,416 | NS | 0.21161% |
| IDYA | IDEAYA Biosciences, Inc. | 4,907 | NS | 0.208609% |
| TXG | 10x Genomics, Inc. | 6,513 | NS | 0.198204% |
| TVTX | Travere Therapeutics, Inc. | 4,995 | NS | 0.196457% |
| Apellis Pharmaceuticals, Inc. | Apellis Pharmaceuticals, Inc. | 7,068 | NS | 0.195591% |
| VERA | Vera Therapeutics, Inc. | 3,585 | NS | 0.193065% |
| Centessa Pharmaceuticals PLC | Centessa Pharmaceuticals PLC | 5,405 | NS | 0.191674% |
| IRON | Disc Medicine, Inc. | 2,105 | NS | 0.185147% |
| ADPT | Adaptive Biotechnologies Corp. | 8,546 | NS | 0.180753% |
| WVE | Wave Life Sciences Ltd. | 9,352 | NS | 0.171995% |
| MLYS | Mineralys Therapeutics, Inc. | 4,428 | NS | 0.171058% |
| RARE | Ultragenyx Pharmaceutical Inc. | 5,405 | NS | 0.166912% |
| DYN | Dyne Therapeutics, Inc. | 7,965 | NS | 0.164258% |
| MAZE | Maze Therapeutics, Inc. | 2,678 | NS | 0.161191% |
| STOK | Stoke Therapeutics, Inc. | 3,184 | NS | 0.153057% |
| GRAL | GRAIL, Inc. | 2,176 | NS | 0.152924% |
| KNSA | Kiniksa Pharmaceuticals International, PLC | 2,538 | NS | 0.149078% |
| HROW | Harrow, Inc. | 2,072 | NS | 0.148214% |
| OLMA | Olema Pharmaceuticals, Inc. | 4,401 | NS | 0.140614% |
| OCUL | Ocular Therapeutix, Inc. | 11,885 | NS | 0.14028% |
| SNDX | Syndax Pharmaceuticals, Inc. | 4,873 | NS | 0.139674% |
| RXRX | Recursion Pharmaceuticals, Inc. | 28,735 | NS | 0.139232% |
SEC N-PORT snapshot as of .